
dana-farber.org
Aug 12, 2025, 14:40
The Launch of BrightSeq – Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared on LinkedIn:
“In collaboration with Boston Children’s Hospital and Broad Clinical Labs, we’re excited to announce the launch of BrightSeq – a new precision genomics initiative set to advance pediatric cancer diagnostics and research.
“This collaborative model will empower us to address urgent needs in pediatric cancer research while also returning critical results to patients and families,” noted Kimberly Stegmaier, Chair of the Department of Pediatric Oncology.
More posts featuring Dana-Farber Cancer Institute.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 12, 2025, 14:40
Aug 12, 2025, 14:32
Aug 12, 2025, 14:13
Aug 12, 2025, 13:44
Aug 12, 2025, 13:21
Aug 12, 2025, 13:00
Aug 12, 2025, 12:34
Aug 12, 2025, 12:34
Aug 12, 2025, 12:21
Aug 12, 2025, 12:18
Aug 12, 2025, 12:18